Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:Company
|
| gptkbp:archaeological_findings |
discovered in 1921
insulin discovered by Banting and Best |
| gptkbp:associated_with |
HLA genes
other autoimmune diseases |
| gptkbp:caused_by |
autoimmune destruction of beta cells
|
| gptkbp:complications |
eye damage
heart disease kidney damage nerve damage ketoacidosis |
| gptkbp:disease_resistance |
gptkb:battle
|
| gptkbp:emergency_services |
glucagon injection
hypoglycemia treatment ketoacidosis treatment |
| https://www.w3.org/2000/01/rdf-schema#label |
Type 1 diabetes
|
| gptkbp:influenced_by |
affects quality of life
requires daily management requires dietary adjustments requires physical activity monitoring |
| gptkbp:is_involved_in |
gptkb:Diabetes_UK
gptkb:JDRF gptkb:Type_1_Diabetes_Network |
| gptkbp:is_popular_in |
increasing worldwide
less than 10% of diabetes cases |
| gptkbp:issues |
can be cured
only affects children caused by sugar consumption is the same as Type 2 diabetes |
| gptkbp:manager |
education and training
continuous glucose monitoring insulin pumps |
| gptkbp:premiered_on |
usually in childhood or adolescence
|
| gptkbp:public_awareness |
gptkb:November
|
| gptkbp:receives_funding_from |
significant funding for research
|
| gptkbp:research_focus |
gptkb:vaccine
artificial pancreas beta cell regeneration |
| gptkbp:risk_factor |
family history
|
| gptkbp:social_responsibility |
blood tests
A1 C test fasting blood glucose oral glucose tolerance test random blood glucose test |
| gptkbp:symptoms |
fatigue
frequent urination increased thirst blurred vision extreme hunger |
| gptkbp:treatment |
insulin therapy
blood sugar monitoring diet management |